Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.
about
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerComparison of Prognostic MicroRNA Biomarkers in Blood and Tissues for Gastric CancerEmerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implicationsNew blood markers detection technology: A leap in the diagnosis of gastric cancerDysregulation of non-coding RNAs in gastric cancerMay Circulating microRNAs be Gastric Cancer Diagnostic Biomarkers?Molecular classification and prediction in gastric cancerChallenges of deciphering gastric cancer heterogeneityGenome-wide analysis of microRNA and mRNA expression signatures in cancerClinical application of microRNA in gastric cancer in Eastern Asian areaPerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsRole of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewCurcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly alteredA novel microRNA signature predicts survival in stomach adenocarcinoma.MicroRNAs as potential biomarkers for gastric cancer.MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor statusPrognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis.Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.A potentially functional variant in the serotonin transporter gene is associated with premenopausal and perimenopausal hot flashes.gga-miR-375 plays a key role in tumorigenesis post subgroup J avian leukosis virus infection.Identification of microRNAs and their target genes in Alport syndrome using deep sequencing of iPSCs samples.Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasisMicroRNAs as a potential prognostic factor in gastric cancer.MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2.High-Throughput Sequencing of miRNAs Reveals a Tissue Signature in Gastric Cancer and Suggests Novel Potential BiomarkersLow-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas.MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphomamicroRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTENHsa-miR-375 is a predictor of local control in early stage breast cancer.Reduction of gastric cancer proliferation and invasion by miR-15a mediated suppression of Bmi-1 translation.Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.Dysregulation of MicroRNA-196b-5p and MicroRNA-375 in Gastric Cancer.Biomarkers of Helicobacter pylori-associated gastric cancer.Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression.The emerging role of miR-375 in cancer.MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas.Seven protective miRNA signatures for prognosis of cervical cancer.Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation.The clinical value of ncRNAs in gastric cancer: a systematic review and meta-analyses.
P2860
Q26744362-7EFD110F-10DE-4F8D-AFF3-2265BA61C4FCQ26771422-E4D23AA7-57F8-4220-928B-3AF81E83D8ABQ26774498-6E7BFEFA-6082-491D-B7BA-4E557E95E0D8Q26774503-54B7BE7D-F75A-4683-A6F7-5A18FCCCDFA3Q26780293-75B78D1B-99AD-4A10-977B-D08992B81E87Q26780339-2D3D48E0-825C-41AA-A5F5-449709746B77Q26783806-C7479415-F9A7-4872-8B26-1BCDFA73DFCAQ26784448-CF764E48-A783-4DAB-AFBE-AA8C207BBD8BQ26795603-05A74D5E-2AD6-4145-BEE4-A39B3A2BA15CQ26829583-0049F7DF-F78A-4D14-9AB4-9BC56046E453Q27012898-BDD39CA3-70D2-430D-8E33-8D1876B03549Q28086989-050067B9-E597-44C2-9FE8-9ACA5E3F8A60Q28537584-9D2C0F71-323A-4474-BE07-6D52BC179CFBQ33709612-4F9ADA81-9A3A-4F6B-9FB5-314724B406DDQ34168445-B66D785E-6CF1-4055-93CB-4F046D934F4FQ34314082-D98F7242-9A62-4DDD-8EE4-4137D13A2BF7Q34488086-D5A389AB-20E9-430B-B09E-93CCB8B52D09Q34663943-00ED2FD8-0FDB-4D44-81B4-E4050AE53CF5Q34735140-39484959-902A-4C4E-B05B-D1ADED1A657FQ35138234-2764FFCB-27FF-4B6C-B990-B39D8687AC98Q35170636-48CDD45F-4F14-4761-9264-FDE9CD16E3ACQ35402769-F360230F-6A97-482E-80B2-2194E3C6FBAEQ35424564-B3DFFB38-5854-42E0-A3E2-85262EC51A0BQ35671794-77831A17-B038-4992-AB0E-D2AB5A5A2DBAQ35799323-6CBD2EC1-A202-41E8-B8B1-D877F10F0D2EQ35952029-1BD4189D-147C-40A7-9D87-23D7DA2EBC4BQ36530696-2463507B-91B3-4F7B-A2DD-CED9136EB314Q36642781-E54C48CB-95B2-4B2C-A800-9FC6994D5173Q36668028-80244A4F-FBAB-4B18-BF09-DE8361A24538Q37046660-56C872AB-48E3-4555-BC68-0E8C83935F96Q37209628-163324BB-3264-4FE9-BD38-60619465ED22Q37537123-B5C4D6E5-A94D-4FCE-8592-38F09041C7ABQ37549197-22447E42-0525-4EB3-B02E-C9450931D781Q37591506-ECB79A5E-F959-40FC-B694-7D539142C9A9Q37717333-2B7A27DC-FE2D-48F3-9F4E-D5D6CEE0DA5DQ38156047-EF4C7969-C008-492F-AF52-053EBE31FCF8Q38325779-58C6E8D0-1018-4CEF-9BFA-6E002616C330Q38444530-A4086626-BF6D-4157-9DE7-3129E98B7A16Q38514962-8D2D0C2B-2E07-4730-95D9-335FDF099393Q38550257-15C7E9F1-DCA9-4EFE-B8B7-03B5D04F810D
P2860
Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Combination of hsa-miR-375 and ...... following surgical resection.
@en
Combination of hsa-miR-375 and ...... following surgical resection.
@nl
type
label
Combination of hsa-miR-375 and ...... following surgical resection.
@en
Combination of hsa-miR-375 and ...... following surgical resection.
@nl
prefLabel
Combination of hsa-miR-375 and ...... following surgical resection.
@en
Combination of hsa-miR-375 and ...... following surgical resection.
@nl
P2093
P2860
P356
P1433
P1476
Combination of hsa-miR-375 and ...... following surgical resection.
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDQ758
P577
2011-02-22T00:00:00Z